Alembic Pharmaceuticals
-
November 09, 2020, Monday
Alembic Pharma gets tentative USFDA nod for breast cancer treatment drug
Drug firm Alembic Pharmaceuticals said it has received tentative approval from the US health regulator for Palbociclib capsules, ...
-
November 08, 2020, Sunday
Samvat 2077: Investors must look for safety first, tone down expectations
Given the sharp volatility, it is preferable to stick to leaders or top-tier players across sectors as they consolidate their ...
-
October 22, 2020, Thursday
Alembic Pharma's Q2 net profit up 35% at Rs 333 cr on strong domestic biz
Consolidated total income up 17.65 per cent at Rs 1,460.32 cr in Q2 of FY21 as against Rs 1.241.23 cr a year ago
-
October 22, 2020, Thursday
Alembic Pharma reports 35% rise in net profit to Rs 333 cr for Sept quarter
The company had posted a net profit of Rs 246.27 crore for the corresponding period of the previous fiscal, Alembic Pharma said ...
-
October 22, 2020, Thursday
Alembic Pharma JV gets USFDA nod for antifungal topical solution
Drug firm Alembic Pharmaceuticals said its joint venture firm Aleor Dermaceuticals has received final approval from the US health ...
-
October 16, 2020, Friday
Alembic Pharma gets USFDA nod for anti-viral drug Amantadine Hydrochloride
Drug firm Alembic Pharmaceuticals said it has received approval from the US health regulator for Amantadine Hydrochloride ...
-
September 29, 2020, Tuesday
Stock tips by Nilesh Jain of Anand Rathi: Buy Radico Khaitan, Shoppers Stop
The stock of Radico Khaitan has found the support of its rising trend line and has also formed a reversal candle on the daily ...
-
September 07, 2020, Monday
Alembic Pharma arm gets tentative USFDA nod for drug to treat hypertension
Alembic Pharmaceuticals said its subsidiary has received tentative approval from the US health regulator for Treprostinil ...
-
July 22, 2020, Wednesday
Alembic Pharma Q1 PBT almost doubles to Rs 359 cr, income rises 40%
Company attributes the huge spike to a strong show in the international markets
-
July 22, 2020, Wednesday
Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings
The company reported a net profit of Rs 301 crore in Q1FY21, against Rs 124 crore in the year-ago quarter.
